GXFC3 (Combivir 150 mg / 300 mg)
Generic Name: lamivudine/zidovudine
Pill with imprint GXFC3 is White, Elliptical/Oval and has been identified as Combivir 150 mg / 300 mg. It is supplied by GlaxoSmithKline.
Combivir is used in the treatment of hiv infection; nonoccupational exposure; occupational exposure and belongs to the drug class antiviral combinations. Risk cannot be ruled out during pregnancy. Combivir 150 mg / 300 mg is not a controlled substance under the Controlled Substances Act (CSA).
Images for GXFC3
Combivir
- Generic Name
- lamivudine/zidovudine
- Imprint
- GXFC3
- Strength
- 150 mg / 300 mg
- Color
- White
- Size
- 17.00 mm
- Shape
- Elliptical/Oval
- Availability
- Prescription only
- Drug Class
- Antiviral combinations
- Pregnancy Category
- C - Risk cannot be ruled out
- CSA Schedule
- Not a controlled drug
- Labeler / Supplier
- GlaxoSmithKline
- National Drug Code (NDC)
- 00173-0595 (Discontinued)
- Inactive Ingredients
-
silicon dioxide,
hypromelloses,
magnesium stearate,
microcrystalline cellulose,
polyethylene glycol,
polysorbate 80,
sodium starch glycolate type A potato,
titanium dioxide
Note: Inactive ingredients may vary.
Related images for "GXFC3"
More about Combivir (lamivudine / zidovudine)
- Side effects
- Drug interactions
- Dosage information
- During pregnancy
- Reviews (4)
- Drug images
- Compare alternatives
- Pricing & coupons
- Generic availability
- En español
- Drug class: antiviral combinations
Patient resources
Related treatment guides
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.